Premium
PCSK9 inhibitors for COVID‐19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia
Author(s) -
Vuorio A.,
Kovanen P. T.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13210
Subject(s) - medicine , pcsk9 , endothelial dysfunction , dengue fever , statin , immunology , cholesterol , lipoprotein , interferon , ldl receptor